Qian-ru Feng, Jie-jing Yu, Jing-jing Zhan, Yi-juan Xu, Yeuk-lung Chow, Shun-jun Xu, Liu Yang
{"title":"川可治在大鼠体内代谢研究。","authors":"Qian-ru Feng, Jie-jing Yu, Jing-jing Zhan, Yi-juan Xu, Yeuk-lung Chow, Shun-jun Xu, Liu Yang","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>To study the metabolic products of main compounds of Chuankezhi injection in rat, 12 Sprague\nDawley rats were classed into 2 groups, a blank control group and an intermuscular administration group,\nrespectively. Rat feces and urine samples were collected from 0−24 h and 24−48 h after administration. All\nthe samples were ultrasonically treated with methanol and then analyzed using LC-LTQ Orbitrap MSn. By\ncomparison with the total ion chromatogram of samples from the blank control group, the metabolites in the\nsamples of drug-treated group were screened. These metabolites were further analyzed by multistage product\nion scanning and comparison of retention time with reference substances. As a result, a total of 12 flavonoid\nmetabolites were tentatively identified from the rat feces and no metabolite was discovered in the rat urine.\nEpimedin C and icariin were detected in the rat blood samples after 30 min of administration, but their\nmetabolites and other original flavones were not detected. Furthermore, no original flavones and their\nmetabolites were detected in rat blood samples after 2 and 4 h of administration. The potential metabolism\npaths were further characterized and the principal in vivo transformation of flavones from Chuankezhi injection\nwere deglycosylation, dehydration, methylation, oxidation and isomerization in rats.</p>","PeriodicalId":35924,"journal":{"name":"药学学报","volume":"52 3","pages":"449-55"},"PeriodicalIF":0.0000,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[In vivo study of Chuankezhi metabolism in rat].\",\"authors\":\"Qian-ru Feng, Jie-jing Yu, Jing-jing Zhan, Yi-juan Xu, Yeuk-lung Chow, Shun-jun Xu, Liu Yang\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>To study the metabolic products of main compounds of Chuankezhi injection in rat, 12 Sprague\\nDawley rats were classed into 2 groups, a blank control group and an intermuscular administration group,\\nrespectively. Rat feces and urine samples were collected from 0−24 h and 24−48 h after administration. All\\nthe samples were ultrasonically treated with methanol and then analyzed using LC-LTQ Orbitrap MSn. By\\ncomparison with the total ion chromatogram of samples from the blank control group, the metabolites in the\\nsamples of drug-treated group were screened. These metabolites were further analyzed by multistage product\\nion scanning and comparison of retention time with reference substances. As a result, a total of 12 flavonoid\\nmetabolites were tentatively identified from the rat feces and no metabolite was discovered in the rat urine.\\nEpimedin C and icariin were detected in the rat blood samples after 30 min of administration, but their\\nmetabolites and other original flavones were not detected. Furthermore, no original flavones and their\\nmetabolites were detected in rat blood samples after 2 and 4 h of administration. The potential metabolism\\npaths were further characterized and the principal in vivo transformation of flavones from Chuankezhi injection\\nwere deglycosylation, dehydration, methylation, oxidation and isomerization in rats.</p>\",\"PeriodicalId\":35924,\"journal\":{\"name\":\"药学学报\",\"volume\":\"52 3\",\"pages\":\"449-55\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"药学学报\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"药学学报","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
To study the metabolic products of main compounds of Chuankezhi injection in rat, 12 Sprague
Dawley rats were classed into 2 groups, a blank control group and an intermuscular administration group,
respectively. Rat feces and urine samples were collected from 0−24 h and 24−48 h after administration. All
the samples were ultrasonically treated with methanol and then analyzed using LC-LTQ Orbitrap MSn. By
comparison with the total ion chromatogram of samples from the blank control group, the metabolites in the
samples of drug-treated group were screened. These metabolites were further analyzed by multistage product
ion scanning and comparison of retention time with reference substances. As a result, a total of 12 flavonoid
metabolites were tentatively identified from the rat feces and no metabolite was discovered in the rat urine.
Epimedin C and icariin were detected in the rat blood samples after 30 min of administration, but their
metabolites and other original flavones were not detected. Furthermore, no original flavones and their
metabolites were detected in rat blood samples after 2 and 4 h of administration. The potential metabolism
paths were further characterized and the principal in vivo transformation of flavones from Chuankezhi injection
were deglycosylation, dehydration, methylation, oxidation and isomerization in rats.
药学学报Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.20
自引率
0.00%
发文量
0
期刊介绍:
Acta Pharmaceutica Sinica B (APSB) is a bimonthly English peer-reviewed online journal in ScienceDirect, which publishes significant original research articles, communications and high quality reviews of recent advances. APSB encourages submissions from all areas of pharmaceutical sciences, including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.
APSB is a part of the series Acta Pharmaceutica Sinica, which was founded in 1953. The journal is co-published by Elsevier B.V., in association with the Institute of MateriaMedica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical Association.